Preclinical Development and First-in-Human Study of KA2507, a Selective and Potent Inhibitor of Histone Deacetylase 6, for Patients with Refractory Solid Tumors
KA2507(一种选择性强效的组蛋白去乙酰化酶 6 抑制剂)治疗难治性实体瘤患者的临床前开发和首次人体研究
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-21-0238
Tsimberidou, Apostolia M; Beer, Philip A; Cartwright, Carrie A; Haymaker, Cara; Vo, Henry H; Kiany, Simin; Cecil, Alexander R L; Dow, James; Haque, Kemal; Silva, Franck A; Coe, Lucy; Berryman, Helen; Bone, Elisabeth A; Nogueras-Gonzalez, Graciela M; Vining, David; McElwaine-Johnn, Hilary; Wistuba, Ignacio I